BRNS Scorecard | BARINTHUS BIOTHERAPEUTICS PLC

BARINTHUS BIOTHERAPEUTICS PLC (BRNS) Scorecard

2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
2025-Q3: Total return Win; Revenue growth Lose; EPS growth Win.

40 QUARTERS × 3 ROAST BATTLES

16/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

Quarter	Total return	Revenue growth	EPS growth
2026-Q21/3	WinBRNS / S&P 15.99% / 15.20%	LoseBRNS / S&P BRNS unavailable / 15.00%	LoseBRNS / S&P -40.46% / 50.40%
2026-Q10/3	LoseBRNS / S&P -18.71% / -4.33%	LoseBRNS / S&P BRNS unavailable / 11.30%	LoseBRNS / S&P -21.34% / 27.70%
2025-Q40/3	LoseBRNS / S&P -44.00% / 2.65%	LoseBRNS / S&P BRNS unavailable / 9.00%	LoseBRNS / S&P 5.81% / 13.40%
2025-Q32/3	WinBRNS / S&P 34.41% / 8.12%	LoseBRNS / S&P BRNS unavailable / 4.61%	WinBRNS / S&P 26.17% / 13.45%
2025-Q20/3	LoseBRNS / S&P -4.42% / 10.94%	LoseBRNS / S&P BRNS unavailable / 4.83%	LoseBRNS / S&P 4.85% / 10.63%
2025-Q10/3	LoseBRNS / S&P -19.45% / -4.27%	LoseBRNS / S&P BRNS unavailable / 4.98%	LoseBRNS / S&P -10.87% / 10.57%
2024-Q41/3	LoseBRNS / S&P 1.51% / 2.41%	WinBRNS / S&P 1766.46% / 5.25%	LoseBRNS / S&P -19.27% / 6.15%
2024-Q31/3	LoseBRNS / S&P -15.00% / 5.89%	WinBRNS / S&P 106.21% / 5.89%	LoseBRNS / S&P -26.24% / 6.11%
2024-Q21/3	LoseBRNS / S&P -41.18% / 4.28%	LoseBRNS / S&P -100.00% / 5.38%	WinBRNS / S&P 15.38% / 5.12%
2024-Q11/3	LoseBRNS / S&P -35.50% / 10.56%	LoseBRNS / S&P -98.89% / 5.71%	WinBRNS / S&P 360.00% / 5.59%
2023-Q41/3	WinBRNS / S&P 19.42% / 11.69%	LoseBRNS / S&P -98.21% / 6.81%	LoseBRNS / S&P -1397.30% / 7.78%
2023-Q31/3	WinBRNS / S&P 50.00% / -3.27%	LoseBRNS / S&P -81.02% / 7.52%	LoseBRNS / S&P -735.22% / -5.03%
2023-Q21/3	LoseBRNS / S&P -8.04% / 8.74%	LoseBRNS / S&P -58.18% / 9.50%	WinBRNS / S&P 4368.75% / -8.57%
2023-Q11/3	LoseBRNS / S&P -4.68% / 7.50%	WinBRNS / S&P 100.07% / 10.77%	LoseBRNS / S&P -63.03% / -15.69%
2022-Q41/3	LoseBRNS / S&P -26.56% / 7.56%	WinBRNS / S&P 16580.22% / 11.88%	LoseBRNS / S&P -104.85% / -17.99%
2022-Q31/3	LoseBRNS / S&P -28.09% / -4.88%	WinBRNS / S&P 6038.84% / 13.47%	LoseBRNS / S&P -107.97% / -1.41%
2022-Q22/3	WinBRNS / S&P -14.42% / -16.10%	WinBRNS / S&P 732.66% / 13.71%	LoseBRNS / S&P -99.17% / 11.04%
2022-Q11/3	LoseBRNS / S&P -53.20% / -4.60%	WinBRNS / S&P 247.98% / 15.97%	LoseBRNS / S&P BRNS unavailable / 42.23%
2021-Q40/3	LoseBRNS / S&P -29.42% / 11.03%	LoseBRNS / S&P -94.44% / 15.00%	LoseBRNS / S&P BRNS unavailable / 96.40%
2021-Q30/3	LoseBRNS / S&P -6.20% / 0.58%	LoseBRNS / S&P BRNS unavailable / 10.77%	LoseBRNS / S&P BRNS unavailable / 69.42%
2021-Q20/3	LoseBRNS / S&P BRNS unavailable / 8.55%	LoseBRNS / S&P BRNS unavailable / 6.58%	LoseBRNS / S&P BRNS unavailable / 51.81%
2021-Q10/3	LoseBRNS / S&P BRNS unavailable / 6.17%	LoseBRNS / S&P BRNS unavailable / -1.06%	LoseBRNS / S&P BRNS unavailable / 7.39%
2020-Q40/3	LoseBRNS / S&P BRNS unavailable / 12.15%	LoseBRNS / S&P BRNS unavailable / -3.72%	LoseBRNS / S&P BRNS unavailable / -33.42%
2020-Q30/3	LoseBRNS / S&P BRNS unavailable / 8.93%	LoseBRNS / S&P BRNS unavailable / -2.04%	LoseBRNS / S&P BRNS unavailable / -27.10%
2020-Q20/3	LoseBRNS / S&P BRNS unavailable / 20.54%	LoseBRNS / S&P BRNS unavailable / -0.46%	LoseBRNS / S&P BRNS unavailable / -27.11%
2020-Q10/3	LoseBRNS / S&P BRNS unavailable / -19.60%	LoseBRNS / S&P BRNS unavailable / 3.47%	LoseBRNS / S&P BRNS unavailable / -14.75%
2019-Q40/3	LoseBRNS / S&P BRNS unavailable / 9.07%	LoseBRNS / S&P BRNS unavailable / 5.36%	LoseBRNS / S&P BRNS unavailable / 2.99%
2019-Q30/3	LoseBRNS / S&P BRNS unavailable / 1.70%	LoseBRNS / S&P BRNS unavailable / 5.02%	LoseBRNS / S&P BRNS unavailable / 0.21%
2019-Q20/3	LoseBRNS / S&P BRNS unavailable / 4.30%	LoseBRNS / S&P BRNS unavailable / 6.64%	LoseBRNS / S&P BRNS unavailable / 8.65%
2019-Q10/3	LoseBRNS / S&P BRNS unavailable / 13.65%	LoseBRNS / S&P BRNS unavailable / 8.12%	LoseBRNS / S&P BRNS unavailable / 14.29%
2018-Q40/3	LoseBRNS / S&P BRNS unavailable / -13.52%	LoseBRNS / S&P BRNS unavailable / 9.05%	LoseBRNS / S&P BRNS unavailable / 18.23%
2018-Q30/3	LoseBRNS / S&P BRNS unavailable / 7.71%	LoseBRNS / S&P BRNS unavailable / 10.21%	LoseBRNS / S&P BRNS unavailable / 19.06%
2018-Q20/3	LoseBRNS / S&P BRNS unavailable / 3.43%	LoseBRNS / S&P BRNS unavailable / 9.03%	LoseBRNS / S&P BRNS unavailable / 14.46%
2018-Q10/3	LoseBRNS / S&P BRNS unavailable / -0.76%	LoseBRNS / S&P BRNS unavailable / 7.68%	LoseBRNS / S&P BRNS unavailable / 12.46%
2017-Q40/3	LoseBRNS / S&P BRNS unavailable / 6.64%	LoseBRNS / S&P BRNS unavailable / 7.03%	LoseBRNS / S&P BRNS unavailable / 13.82%
2017-Q30/3	LoseBRNS / S&P BRNS unavailable / 4.48%	LoseBRNS / S&P BRNS unavailable / 5.68%	LoseBRNS / S&P BRNS unavailable / 17.57%
2017-Q20/3	LoseBRNS / S&P BRNS unavailable / 3.09%	LoseBRNS / S&P BRNS unavailable / 4.83%	LoseBRNS / S&P BRNS unavailable / 17.74%
2017-Q10/3	LoseBRNS / S&P BRNS unavailable / 6.07%	LoseBRNS / S&P BRNS unavailable / 3.67%	LoseBRNS / S&P BRNS unavailable / 13.32%
2016-Q40/3	LoseBRNS / S&P BRNS unavailable / 3.82%	LoseBRNS / S&P BRNS unavailable / 2.09%	LoseBRNS / S&P BRNS unavailable / 7.05%
2016-Q30/3	LoseBRNS / S&P BRNS unavailable / 3.85%	LoseBRNS / S&P BRNS unavailable / 0.20%	LoseBRNS / S&P BRNS unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

Metric	BRNS total return	S&P 500 Total Return Index
Total return	-34.73%	20.78%
Annualized return	-34.73%	20.78%

5Y · 2021-09-01 to 2026-08-27

Metric	BRNS total return	S&P 500 Total Return Index
Total return	-95.03%	83.14%
Annualized return	-45.13%	12.86%

10Y · 2021-04-30 to 2026-08-27

Metric	BRNS total return	S&P 500 Total Return Index
Total return	-94.82%	319.30%
Annualized return	-25.62%	15.41%

Calculation rules

window: Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis: Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule: Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency: Quarter endpoints only.
fundamentals: Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.